Inhibitory effect of resveratrol and its derivatives on HBV in vitro

Xia ZHOU,Qiu-jun L(U),Lin WANG,Qi-nong YE,Li-qing WEN,Min ZHANG

DOI: https://doi.org/10.3321/j.issn:1001-2494.2005.24.021

2005-01-01

Abstract:OBJECTIVE: To investigate the anti-HBV effect of resveratrol and its derivatives in vitro, and observe their structure response relationship. METHODS: The cytoxicity of compounds on HepG2.2.15 cell was detected using MTT. The levels of HBsAg or HBeAg in the cultured supernatant of HepG 2.2.15 were tested by ELISA. The content of total HBV DNA was quantified by Taqman real-time PCR, and FACS was employed to test the effect of resveratrol on apoptosis in HepG2.2.15. RESULTS: The therapeutic indexs(TI) of resveratrol were (3.26 ± 0.39)(HBsAg) and (2.91 ± 0.12)(HBeAg), respectively. Quantitative real-time-PCR result revealed that resveratrol significantly inhibited total HBV DNA copies in HepG2.2.15 cell at the concentration with lower or no cytoxicity. The effect of resveratrol on apoptosis in HepG2.2.15 appeared aconcentration-dependent pattern. CONCLUSION: Resveratrol is effective in inhibiting HBV in vitro, perhaps by inhibiting HBV copy and inducing apoptosis in HepG2.2.15 cell. In general, the inhibitory effect on HBsAg, HBeAg and HBV DNA copy number in vitro shows that resveratrol-glycoside and 4′-methoxy-3,3,5′-stilbene -3-glucoside are more effective than resveratrol.